IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms
Parasitic helminths are a major cause of chronic human disease, affecting more than 3 billion people worldwide. Host protection against most parasitic helminths relies upon Type 2 cytokine production, but the mechanisms that regulate interleukin (IL) 4 and 13 production from CD4⁺ R helper 2 cells (T...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 110; no. 1; pp. 282 - 287 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
02.01.2013
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Parasitic helminths are a major cause of chronic human disease, affecting more than 3 billion people worldwide. Host protection against most parasitic helminths relies upon Type 2 cytokine production, but the mechanisms that regulate interleukin (IL) 4 and 13 production from CD4⁺ R helper 2 cells (TH2) and innate lymphoid type 2 cells (ILC2s) remain incompletely understood. The epithelial cell-derived cytokines IL-25 and IL-33 promote Type 2 responses, but the extent of functional redundancy between these cytokines is unclear and whether Type 2 memory relies upon either IL-25 or IL-33 is unknown. Herein, we demonstrate a pivotal role for IL-33 in driving primary and anamnestic immunity against the rodent hookworm Nippostrongylus brasiliensis. IL-33-def icient mice have a selective defect in ILC2-derived IL-13 during both primary and secondary challenge infections but generate stronger canonical CD4⁺ T helper 2 cells responses (IL-4, IgE, mast cells, and basophils) than WT controls. Lack of IL-13 production in IL-33-deficient mice impairs resistin-like molecule beta (RELMβ) expression and eosinophil recruitment, which are two mechanisms that eliminate N. brasiliensis parasites from infected hosts. Thus, IL-33 is requisite for IL-13 but not IL-4-driven Type 2 responses during hookworm infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: L.A.D. and D.R.H. designed research; L.-Y.H., I.P.L., L.A.D., J.D., Y.Y., and D.R.H. performed research; D.E.S. contributed new reagents/analytic tools; L.-Y.H., I.P.L., L.A.D., and D.R.H. analyzed data; and L.-Y.H., I.P.L., L.A.D., J.D., and D.R.H. wrote the paper. Edited by Richard A. Flavell, Howard Hughes Medical Institute and Yale School of Medicine, New Haven, CT, and approved November 19, 2012 (received for review April 25, 2012) 1L.-Y.H. and I.P.L. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1206587110 |